Cairo, Egypt, March 11 2023: Zoladex LA 10.8mg goserelin acetate implant anti neoplastic indicated in endometriosis, endometrial thinning, breast cancer and prostate cancer by AstraZeneca UK — Stock Editorial Photography
L
2000 × 1333JPG6.67 × 4.44" • 300 dpiStandard License
XL
6000 × 4000JPG20.00 × 13.33" • 300 dpiStandard License
super
12000 × 8000JPG40.00 × 26.67" • 300 dpiStandard License
EL
6000 × 4000JPG20.00 × 13.33" • 300 dpiExtended License
Cairo, Egypt, March 11 2023: Zoladex LA 10.8mg goserelin acetate implant anti neoplastic indicated in endometriosis, endometrial thinning, breast cancer and prostate cancer by AstraZeneca UK
— Photo by Tamer_Soliman- AuthorTamer_Soliman
- 645696118
- Find Similar Images
Editorial Photo Keywords:
- sc
- system
- endometriosis
- safe
- reduce
- United Kingdom
- treatment
- cancer
- tumor
- management
- palliative
- er
- lower
- receptor
- syringe
- illustrative editorial
- uk
- oestrogen
- thinning
- malignancy
- injection
- astrazeneca
- prostate
- Goserelin
- subcutaneous
- hormonal
- testosterone
- hestaminic
- anti
- prophylaxis
- uterine
- endometrial
- prophylactic
- selective focus
- la
- zoladex
- depot
- abdomen
- hormone
- malignant
- acetate
- carcinoma
- astra zeneca
- long
- acting
- hormones
- prefilled
Same Series:
Usage Information
You can use this royalty-free editorial photo "Cairo, Egypt, March 11 2023: Zoladex LA 10.8mg goserelin acetate implant anti neoplastic indicated in endometriosis, endometrial thinning, breast cancer and prostate cancer by AstraZeneca UK" for personal and non-commercial purposes according to the Standard License. This stock image may be used to illustrate stories in newspaper and magazine articles and blog posts. Please note that editorial stock photos may not be used in advertising or promotional material.
You can buy this editorial photograph and download it in high resolution up to 6000x4000. Upload Date: Mar 13, 2023